NYSE:RERE ATRenew (RERE) Stock Price, News & Analysis → Jim Cramer’s “The Biggest Drug Ever” (From Behind the Markets) (Ad) Free RERE Stock Alerts $1.94 +0.34 (+20.81%) (As of 12:21 PM ET) Add Compare Share Share Today's Range$1.69▼$2.0050-Day Range$1.10▼$1.8552-Week Range$1.01▼$3.30Volume2.59 million shsAverage Volume621,041 shsMarket Capitalization$483.70 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Get ATRenew alerts: Email Address Ad Behind the MarketsJim Cramer’s “The Biggest Drug Ever”This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.Unlock the details of this groundbreaking opportunity here... About ATRenew Stock (NYSE:RERE)ATRenew Inc., through its subsidiaries, operates pre-owned consumer electronics transactions and services platform in the People's Republic of China. It primarily sells mobile phones, laptops, tablets, drones, digital cameras; and vintage bags, watches, liquor, gold, and various household goods through its online platforms and offline stores, as well as provides services to third-party merchants to sell the products through its platforms. The company was formerly known as AiHuiShou International Co. Ltd. and changed its name to ATRenew Inc. November 2021. The company was incorporated in 2011 and is headquartered in Shanghai, the People's Republic of China.Read More RERE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RERE Stock News HeadlinesApril 26, 2024 | prnewswire.comATRenew Inc. Announces Appointment of New DirectorApril 24, 2024 | finance.yahoo.comBreakeven Is Near for ATRenew Inc. (NYSE:RERE)April 26, 2024 | Behind the Markets (Ad)Jim Cramer’s “The Biggest Drug Ever”This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.April 18, 2024 | finance.yahoo.comBamboo Works Spotlights Potential for Smartphone Recycling in Expert Opinion from ATRenew Chairman Kerry ChenApril 12, 2024 | prnewswire.comATRenew Inc. Files 2023 Annual Report on Form 20-FApril 5, 2024 | nasdaq.comATRenew Inc. American Depositary Shares (every three of which representing two Class A ordinary shares) (RERE)April 3, 2024 | investorplace.com7 Growth Stocks to Buy to Outperform the Nasdaq IndexMarch 27, 2024 | finance.yahoo.comRERE: INITIATION: Leading Recycling Platform in China’s Burgeoning Circular EconomyApril 26, 2024 | Behind the Markets (Ad)Jim Cramer’s “The Biggest Drug Ever”This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.March 20, 2024 | markets.businessinsider.comATRenew Polishes Recycling Credentials To Record First ProfitMarch 16, 2024 | seekingalpha.comChina Government Promotes Green Economy, And ATRenew Stands Out As A Main EnablerMarch 15, 2024 | seekingalpha.comATRenew Reported Excellent 2023 Results But The Stock Is UndervaluedMarch 14, 2024 | finance.yahoo.comATRenew Full Year 2023 Earnings: CN¥0.64 loss per share (vs CN¥10.11 loss in FY 2022)March 13, 2024 | msn.comATRenew Inc. (NYSE:RERE) Q4 2023 Earnings Call TranscriptMarch 12, 2024 | msn.comWhy ATRenew Stock Is Climbing After EarningsMarch 12, 2024 | prnewswire.comATRenew Announces US$20 Million Share Repurchase ProgramMarch 12, 2024 | prnewswire.comATRenew Inc. Reports Unaudited Fourth Quarter and Full Year 2023 Financial ResultsFebruary 27, 2024 | finance.yahoo.comATRenew to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024February 27, 2024 | prnewswire.comATRenew to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024February 15, 2024 | finance.yahoo.comChase Coleman's Tiger Global Management Reduces Stake in ATRenew IncFebruary 13, 2024 | finance.yahoo.comATRenew Inc.'s (NYSE:RERE) largest shareholders are retail investors with 36% ownership, public companies own 33%January 1, 2024 | finance.yahoo.comYunji Announces Appointment of New Independent DirectorDecember 18, 2023 | ca.finance.yahoo.comATRenew Inc. (RERE)December 17, 2023 | investing.comATRenew trades at low P/S ratio despite revenue surgeNovember 30, 2023 | finance.yahoo.comATRenew to use Chinese experience to support electronics recycling partners worldwideNovember 25, 2023 | benzinga.comATRenew Stock (NYSE:RERE) Dividends: History, Yield and DatesNovember 24, 2023 | finance.yahoo.comATRenew Inc.'s (NYSE:RERE) Subdued P/S Might Signal An OpportunitySee More Headlines Receive RERE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ATRenew and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/12/2024Today4/26/2024Next Earnings (Estimated)5/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorBusiness Services Industry Retail stores, not elsewhere classified Sub-IndustryN/A Current SymbolNYSE:RERE CUSIPN/A CIK1838957 Webwww.aihuishou.com Phone86-21-5290-7031FaxN/AEmployees2,055Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.10) Trailing P/E RatioN/A Forward P/E Ratio40.25 P/E GrowthN/ANet Income$-22,010,000.00 Net Margins-1.20% Pretax Margin-1.14% Return on Equity2.61% Return on Assets1.94% Debt Debt-to-Equity RatioN/A Current Ratio2.68 Quick Ratio2.07 Sales & Book Value Annual Sales$1.83 billion Price / Sales0.22 Cash Flow$0.25 per share Price / Cash Flow6.55 Book Value$2.10 per share Price / Book0.77Miscellaneous Outstanding Shares248,690,000Free Float222,084,000Market Cap$400.39 million OptionableNot Optionable Beta-0.14 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Xuefeng Chen Kerry (Age 43)Co-Founder, Chairman of the Board of Directors & CEO Mr. Yongliang Wang (Age 39)President & Director Mr. Chen Chen (Age 42)CFO, Compliance Officer & Director Mr. Jeremy JiDirector of Corporate Development & Investor RelationsKey CompetitorsNexxen InternationalNASDAQ:NEXNTTECNASDAQ:TTECGannettNYSE:GCIResources ConnectionNASDAQ:RGPADTRANNASDAQ:ADTNView All CompetitorsInstitutional OwnershipIvyRock Asset Management HK LtdBought 35,000 shares on 2/8/2024Ownership: 0.014%View All Institutional Transactions RERE Stock Analysis - Frequently Asked Questions How have RERE shares performed in 2024? ATRenew's stock was trading at $1.92 at the beginning of the year. Since then, RERE shares have decreased by 0.8% and is now trading at $1.9050. View the best growth stocks for 2024 here. Are investors shorting ATRenew? ATRenew saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 516,600 shares, an increase of 42.7% from the March 31st total of 362,000 shares. Based on an average trading volume of 683,200 shares, the short-interest ratio is presently 0.8 days. View ATRenew's Short Interest. When is ATRenew's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 28th 2024. View our RERE earnings forecast. How were ATRenew's earnings last quarter? ATRenew Inc. (NYSE:RERE) posted its quarterly earnings results on Tuesday, March, 12th. The company reported $0.03 earnings per share (EPS) for the quarter. The company had revenue of $545.58 million for the quarter. ATRenew had a negative net margin of 1.20% and a positive trailing twelve-month return on equity of 2.61%. What guidance has ATRenew issued on next quarter's earnings? ATRenew updated its first quarter 2024 earnings guidance on Tuesday, March, 12th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $500.0 million-$514.1 million. When did ATRenew IPO? ATRenew (RERE) raised $227 million in an initial public offering (IPO) on Friday, June 18th 2021. The company issued 16,200,000 shares at a price of $13.00-$15.00 per share. Goldman Sachs, BofA Securities and China Renaissance served as the underwriters for the IPO and GTJA, CLSA and Tiger Brokers were co-managers. How do I buy shares of ATRenew? Shares of RERE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:RERE) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ATRenew Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
